RXi Pharmaceuticals Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
20,925.00
8,800.00
10,641.00
8,994.00
12,452.00
Depreciation, Depletion & Amortization
99.00
87.00
77.00
53.00
70.00
Other Funds
-
-
-
10,203.00
-
Funds from Operations
6,597.00
6,877.00
8,383.00
8,194.00
8,984.00
Changes in Working Capital
286.00
881.00
1,066.00
434.00
530.00
Net Operating Cash Flow
6,311.00
7,758.00
7,317.00
7,760.00
9,514.00
Capital Expenditures
78.00
95.00
57.00
4.00
203.00
Sale of Fixed Assets & Businesses
-
12.00
-
-
100.00
Purchase/Sale of Investments
3,000.00
3,000.00
5,500.00
5,500.00
-
Net Investing Cash Flow
3,093.00
2,917.00
5,557.00
5,346.00
103.00
Issuance/Reduction of Debt, Net
5.00
-
-
-
-
Net Financing Cash Flow
15,667.00
1,947.00
9,495.00
10,203.00
292.00
Net Change in Cash
6,263.00
2,894.00
3,379.00
7,789.00
9,325.00
Free Cash Flow
6,389.00
7,853.00
7,374.00
7,764.00
9,717.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
1,621.00
Other Sources
3.00
-
-
-
-
Change in Capital Stock
15,672.00
1,947.00
9,495.00
-
292.00
Other Uses
18.00
-
-
150.00
-
About RXi Pharmaceuticals
View Profile
